×

Novo Nordisk CFO: Strong growth in diabetes care

4:15 AM ET Thu, 29 Oct 2015

Jesper Brandgaard, CFO and executive vice-president at Novo Nordisk, says he is optimistic about Tresiba, a next-generation diabetes treatment coming to the market.